# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Sean Wieland maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $57 t...
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and raises the price target from $37...